Morpholino

MO1-elp3

ID

ZDB-MRPHLNO-090216-1

Name

MO1-elp3

Previous Names

None

Target

elp3 (1)

Sequence

5' - TGGCTTTCCCATCTTAGACACAATC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-elp3

Expressed Gene	Anatomy	Figures
col2a1a	notochord	Figure 4 from Rojas-Benítez et al., 2020
elp3	whole organism	Figure 1 from Rojas-Benítez et al., 2020

Phenotype

Phenotype resulting from MO1-elp3

Phenotype	Fish	Figures
adaxial cell ab1-eng labeling decreased amount, abnormal	WT + MO1-elp3	Figure 4 from Rojas-Benítez et al., 2020
horizontal myoseptum morphology, abnormal	WT + MO1-elp3	Figure 2 from Rojas-Benítez et al., 2020
motor neuron axon branched, abnormal	WT + MO1-elp3	Fig. 4 from Simpson et al., 2009
motor neuron axon decreased length, abnormal	WT + MO1-elp3	Fig. S5 from Bento-Abreu et al., 2018 Fig. 4 from Simpson et al., 2009
muscle cell disorganized, abnormal	WT + MO1-elp3	Figure 2 from Rojas-Benítez et al., 2020
notochord col2a1a expression decreased amount, abnormal	WT + MO1-elp3	Figure 4 from Rojas-Benítez et al., 2020
post-vent region curved ventral, abnormal	WT + MO1-elp3	Figure 1 , Figure 5 from Rojas-Benítez et al., 2020
somite decreased area, abnormal	WT + MO1-elp3	Figure 2 from Rojas-Benítez et al., 2020
somite morphology, abnormal	WT + MO1-elp3	Figure 2 from Rojas-Benítez et al., 2020
somite fast muscle cell disorganized, abnormal	WT + MO1-elp3	Figure 3 from Rojas-Benítez et al., 2020
somite slow muscle cell morphology, abnormal	WT + MO1-elp3	Figure 3 from Rojas-Benítez et al., 2020
somite slow muscle cell undulate, abnormal	WT + MO1-elp3	Figure 3 from Rojas-Benítez et al., 2020
trunk curved ventral, abnormal	WT + MO1-elp3	Figure 1 , Figure 5 from Rojas-Benítez et al., 2020
whole organism elp3 expression decreased amount, abnormal	WT + MO1-elp3	Figure 1 from Rojas-Benítez et al., 2020

Phenotype of all Fish created by or utilizing MO1-elp3

Phenotype	Fish	Conditions	Figures
motor neuron axon decreased length, abnormal	AB + MO1-elp3	standard conditions	Fig. S5 from Bento-Abreu et al., 2018
trunk curved ventral, abnormal	WT + MO1-elp3	standard conditions	Figure 1 , Figure 5 from Rojas-Benítez et al., 2020
whole organism elp3 expression decreased amount, abnormal	WT + MO1-elp3	control	Figure 1 from Rojas-Benítez et al., 2020
notochord col2a1a expression decreased amount, abnormal	WT + MO1-elp3	standard conditions	Figure 4 from Rojas-Benítez et al., 2020
adaxial cell ab1-eng labeling decreased amount, abnormal	WT + MO1-elp3	standard conditions	Figure 4 from Rojas-Benítez et al., 2020
post-vent region curved ventral, abnormal	WT + MO1-elp3	standard conditions	Figure 1 , Figure 5 from Rojas-Benítez et al., 2020
somite fast muscle cell disorganized, abnormal	WT + MO1-elp3	standard conditions	Figure 3 from Rojas-Benítez et al., 2020
motor neuron axon branched, abnormal	WT + MO1-elp3	standard conditions	Fig. 4 from Simpson et al., 2009
somite morphology, abnormal	WT + MO1-elp3	standard conditions	Figure 2 from Rojas-Benítez et al., 2020
somite slow muscle cell undulate, abnormal	WT + MO1-elp3	standard conditions	Figure 3 from Rojas-Benítez et al., 2020
muscle cell disorganized, abnormal	WT + MO1-elp3	standard conditions	Figure 2 from Rojas-Benítez et al., 2020
motor neuron axon decreased length, abnormal	WT + MO1-elp3	standard conditions	Fig. 4 from Simpson et al., 2009
somite decreased area, abnormal	WT + MO1-elp3	standard conditions	Figure 2 from Rojas-Benítez et al., 2020
trunk curved, ameliorated	WT + MO1-elp3	chemical treatment by injection: purmorphamine	Figure 5 from Rojas-Benítez et al., 2020
somite slow muscle cell morphology, abnormal	WT + MO1-elp3	standard conditions	Figure 3 from Rojas-Benítez et al., 2020
horizontal myoseptum morphology, abnormal	WT + MO1-elp3	standard conditions	Figure 2 from Rojas-Benítez et al., 2020
post-vent region curved, ameliorated	WT + MO1-elp3	chemical treatment by injection: purmorphamine	Figure 5 from Rojas-Benítez et al., 2020

Citations